Confidence in every breath.

Endolynx’s proprietary sensing technology transforms the traditional endotracheal tube into a precision instrument, enabling the tracking and display of placement data in real time.

THE PROBLEM
65 million pATIENTS WORLDWIDE require a breathing tube.

Errors in endotracheal tube management cause great harm to patients and result in substantial financial burdens for physicians, hospitals, and insurers— costing an estimated $12 billion annually in the U.S. alone.

Every year, at least 65 million people worldwide depend on a breathing tube. This tube serves as a critical lifeline, delivering oxygen with every breath. Yet, despite its importance, there is no robust, reliable system in place to continuously monitor its precise position in real time.

THE SOLUTION

Our patented innovation will redefine the standard of care for endotracheal tube placement and management.

Position Verification

Embedded proprietary sensors allow quantitative depth tracking to ensure precise placement within the trachea. The device continuously monitors tube movement, and immediately identifies esophageal misplacement.

Real-Time Monitoring

Continuous tracking after intubation provides alerts for tube displacement, eliminating gaps between radiographic or manual verification checks when patients are unmonitored and most at risk.

Ease Of Application

Low-profile sensors embedded directly into standard endotracheal tubes allow providers to intubate using customary techniques with minimal training or changes in workflow.

The trachea is only the beginning.

Our modeling studies of the Endolynx sensing platform indicate that this approach is adaptable to the investigation of other internal organs.

Future efforts will explore other clinical applications of this technology, including IUD insertion, catheter placement verification, orogastric tubes, and advanced labor monitoring.

Our Partners & Testimonials

“I believe Endolynx will have a large impact on the very high numbers  of  patients  who  require  this  procedure  during  hospitalization  and  emergency  situations. (...) I look forward to supporting the development of the optical sensor-enabled endotracheal tube.”

Adam Closson, Chemical Angel Network

“This project proposes research on a solution that may decrease severe complications of endotracheal intubation. Additional benefits include less need for X-rays, fewer feeding tube misplacements, and improved ICU/OR efficiency, enhancing care while reducing costs.”

Jeff E. Mandel, MD, MS

“I believe this device may have a significant impact on ventilator-dependent patients in the neonatal intensive care unit (NICU). (...) there is a clear use and need for the data a device like this might provide.”

Yisrael Lipener, MD

“This project proposes research on a solution that may decrease severe complications of endotracheal intubation. Additional benefits include less need for X-rays, fewer feeding tube misplacements, and improved ICU/OR efficiency, enhancing care while reducing costs.”

Jeff E. Mandel, MD, MS

“I believe the novel endotracheal tube that the Endolynx team is working has the potential to contribute to an overall safer environment for intubation and help prevent medical errors. (...) I would very much like to see this technology advance to the next level.”

Bruce Robertson, PhD, H.I.G. Capital

“This device may have a significant impact on ventilator-dependent patients in the operating room and intensive care 
unit. (...) I believe there is a clear use and need that this device will satisfy if it functions safely with high sensitivity and specificity. I strongly support this project.”

Ania Jankowska, MD

A creative Group of Dreamers

David Schaner

Anesthesiologist with over 15 years of clinical experience managing advanced airways.

Felek Jachimowicz, PhD

30 years engineering breakthrough products at WR Grace. Innovation leader with 23 patents in product development.

Robert Jenkins, PhD

40 years transforming operations at WR Grace and Thermo Fisher Scientific. Innovation leader with 8 patents in product development and operational excellence.

Bruce Banter

Over 30 years of extensive experience in sensor design and human-machine interface controls.

Eitan Borgnia

Expert in data analysis and machine learning. Caltech graduate and founder of Relace AI.

Philip Press

Over 50 years’ experience as a statistical consultant to the bio technology and specialty chemical sectors, with a focus on statistical design and analysis of experiments for product and process optimization.

Philip Schaner

Collaborating radiation oncologist at Dartmouth Hitchcock Medical Center who specializes in ENT cancer treatment.

Technology Status

  • Patents granted and pending.
  • NIH SBIR Phase 1 award recipient.
  • Pre-commercial development stage.
  • Design and clinical validation ongoing.